Document is current
Any future updates will be listed below
-
Authors
Takada, Keisuke
Samura, Masaru
Igarashi, Yuki
Suzuki, Ayako
Ishigo, Tomoyuki
Fujii, Satoshi
Ibe, Yuta
Yoshida, Hiroaki
Tanaka, Hiroaki
Ebihara, Fumiya
Maruyama, Takumi
Hamada, Yukihiro
Komatsu, Toshiaki
Tomizawa, Atsushi
Takuma, Akitoshi
Chiba, Hiroaki
Yagi, Yusuke
Nishi, Yoshifumi
Enoki, Yuki
Taguchi, Kazuaki
Tanikawa, Koji
Kunishima, Hiroyuki
Matsumoto, Kazuaki
- License Information
-
More Information
Article History
Received: 7 January 2025
Accepted: 21 February 2025
First Online: 12 March 2025
Declarations
:
: This study was approved by the Yokohama General Hospital Ethics Committee (approval number: 2024–026) for population pharmacokinetic analysis, and by Showa University Ethics Committee for validation of the PPK model (approval number: 22–284-A). Comprehensive informed consent was obtained from the participants by displaying an opt-out option on our website.
: Not applicable.
: HK received speaker honoraria from Shionogi Pharma Co., Ltd. KM received grant support funding from Meiji Seika Pharma Co., Ltd., and Sumitomo Pharma Co., Ltd., and speaker honoraria from Meiji Seika Pharma Co., Ltd. The other authors declare no conflicts of interests.
